Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

NCT03866577 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

50

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated based on Sponsor decision.

Conditions

Immune Thrombocytopenic Purpura (ITP)

Interventions

BIOLOGICAL: Biological: M254
DRUG: Placebo
BIOLOGICAL: Intravenous immunoglobulin (IVIg)

Sponsor

Momenta Pharmaceuticals, Inc.